Range Low Price High Price Comment
30 days $0.0748 $0.0748 Monday, 29th Apr 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0701 $0.110
52 weeks $0.0600 $1.31

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Feb 01, 2016 $11.08 $11.87 $10.81 $11.49 287 300
Jan 29, 2016 $10.87 $11.39 $10.66 $11.30 311 300
Jan 28, 2016 $12.10 $12.13 $10.75 $10.92 537 500
Jan 27, 2016 $12.62 $12.84 $11.77 $11.90 327 700
Jan 26, 2016 $12.84 $12.98 $11.97 $12.68 359 300
Jan 25, 2016 $12.43 $13.43 $12.15 $12.72 582 500
Jan 22, 2016 $12.80 $13.20 $12.34 $12.53 397 800
Jan 21, 2016 $12.99 $13.46 $11.76 $12.18 1 193 900
Jan 20, 2016 $11.54 $13.67 $11.34 $12.97 791 400
Jan 19, 2016 $12.70 $12.71 $11.17 $11.81 605 600
Jan 15, 2016 $12.35 $12.76 $11.76 $12.69 408 800
Jan 14, 2016 $12.70 $13.40 $11.80 $12.96 540 500
Jan 13, 2016 $14.39 $14.39 $12.63 $12.65 324 900
Jan 12, 2016 $14.05 $15.00 $13.47 $14.08 372 900
Jan 11, 2016 $15.45 $15.84 $13.26 $13.78 510 300
Jan 08, 2016 $16.49 $17.18 $15.81 $15.93 373 900
Jan 07, 2016 $18.08 $18.25 $16.16 $16.35 559 200
Jan 06, 2016 $18.97 $19.32 $18.28 $18.49 441 300
Jan 05, 2016 $19.16 $19.85 $18.81 $19.45 249 400
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT